Worldwide Clinical Trials Builds Global Contract Research Organization

Jordan Company Portfolio Company Closes Fifth Acquisition in Last Year
Purchase of MediQuest in Eastern Europe Establishes Premier Global Contract Research Organization

NEW YORK, NY – July 9, 2008 – The Jordan Company, a leading middle-market private equity firm, today announced that Worldwide Clinical Trials, Inc., a premier contract research organization whose global expansion it is sponsoring, has reached an important milestone in its growth. Worldwide Clinical Trials, which is run by an experienced management team under the leadership of Dr. Neal Cutler, has recently completed its fifth acquisition in the last year, acquiring MediQuest, a contract research organization in Eastern Europe providing specialized clinical development services to biopharmaceutical companies and organizations.

Formed in 2007 by Dr. Cutler as CEO in partnership with The Jordan Company, the firm focuses on complex, high-growth therapeutic areas with primary expertise in central nervous system and cardiovascular disease. The company’s other recent acquisitions include Evidence Clinical and Pharmaceutical Research LLC; Clinical Studies Management Group, Inc.; Nottingham Clinical Research Limited; and CEDRA Corporation. The five acquisitions extend Worldwide Clinical Trials global footprint to more than 30 countries.

“The expansion of capability and geographic coverage that Worldwide Clinical Trials has engineered over the past year is a clear sign of their successful efforts to target this growing industry. Working in conjunction with the management team, we have helped to broaden the business through strategic growth and a highly selective strategy to acquire companies that complement its existing skill-set,” said David Butler, a Principal at The Jordan Company. The Jordan Company closed its second institutional private equity fund with $3.6 billion at the beginning of 2008.

“The acquisitions we have completed to date significantly enhance our contract research organization capabilities and our ability to manage large, global trials, within our primary therapeutic areas of focus. That in turn positions us well for future growth,” said Dr. Cutler. “We have effectively expanded our operations and significantly enhanced our ability to meet the global needs of pharma and biotech companies. Our presence in Eastern Europe and Russia, two of the most attractive growth regions for clinical trials, helps transform our business into a truly global contract research organization.”

###

About Worldwide Clinical Trials, Inc.
Worldwide Clinical Trials (www.wwctrials.com) is a full-service contract research organization (CRO) that is medically and scientifically focused on central nervous system and cardiovascular disease. WCT delivers quality clinical trials with leading edge science and medicine to help clients think through design, methodology and regulatory issues that are unique to every development program. WCT provides highly focused CRO services in all phases of research - worldwide.

About The Jordan Company
The Jordan Company (www.thejordancompany.com), founded in 1982, is a leading middle-market private equity firm with over $5 billion of assets under management and a successful track record of investing in and growing businesses across a wide range of industries. The firm’s partners have been investing together for more than two decades, establishing The Jordan Company as one of the most experienced and stable investment teams in private equity. The investment team is supported by the firm’s Operations Management Group, which initiates and supports operational improvements in portfolio companies. The firm generates deal flow through a well-developed network of sourcing relationships. Headquartered in New York, The Jordan Company also has offices in Chicago and Shanghai.

Contact:
Alex Stanton
Stanton Crenshaw Communications
(212) 780-0701
alex@stantoncrenshaw.com

Back